Endocrine Abstracts

Contents

• 20th European Congress of Endocrinology 2018
• • Prize Lectures and Biographical Notes
  • The European Journal of Endocrinology Prize Lecture
  • • A gut feeling about glucagon

      ea0056eje1
    • The European Journal of Endocrinology Prize Lecture

      ea0056eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Geoffrey Harris Award

      ea0056gh1
    • The Geoffrey Harris Prize Lecture

      ea0056gh1biog
  • European Hormone Medal Lecture
  • • Unraveling Secrets of the Hypothalamic-Pituitary-Gonadal Axis

      ea0056ehm1
    • European Hormone Medal Lecture

      ea0056ehm1biog
  • Clinical Endocrinology Trust Lecture
  • • Growth Hormone: not too much… not too less..!

      ea0056cet1
    • Clinical Endocrinology Trust Lecture

      ea0056cet1biog
• Plenary Lectures
• • Contraception: Past and future
  • • Contraception: past, present, and future

      ea0056pl1
  • Bone regulates the Brain
  • • Bone Regulates the Brain to Control Appetite

      ea0056pl2
  • The wonder world of GnRH neurons
  • • The wonder world of GnRH neurons - cracking the pulse generator

      ea0056pl3
  • The Retina as a Window for Exploring the Brain in Diabetes
  • • The Retina as a Window for Exploring the Brain in Diabetes

      ea0056pl4
  • The link between insulin and fatty liver
  • • The link between insulin and fatty liver

      ea0056pl5
  • Does therapy for thyroid dysfunction decrease mortality?
  • • Does therapy for thyroid dysfunction decrease mortality?

      ea0056pl6
  • Metabolic control of longevity
  • • Anti-obesity effect in mice and monkeys of partial inhibition of PI3K[alpha]

      ea0056pl7
• Symposia
• • Predicting events in autoimmune thyroid diseas
  • • The THEA score in familial thyroid dysfunction. Predictive factors of autoimmune thyroid disease

      ea0056s1.1
    • IgG4 related thyroid autoimmune disease

      ea0056s1.2
    • New scores for the prediction of Graves' disease

      ea0056s1.3
  • Salt & Sweet
  • • Hyponatremia and mortality: moving beyond associations

      ea0056s2.1
    • Hereditary diabetes insipidus

      ea0056s2.2
    • Going hedonic - the role of FGF21 in the preference for sweet and alcohol

      ea0056s2.3
  • Bile Acid & Microbiota (Endorsed by Endocrine Connections)
  • • Crosstalk between bile acids and the gut microbiota - influence on host metabolism

      ea0056s3.1
    • Subclinical hypothyroidism is 'not' a disease (Contra)

      ea0056s3.2
    • Bile acids and metabolic effects of bariatric surgery

      ea0056s3.3
  • Environmental effects on endocrine functions
  • • Developmental exposures to endocrine disrupting chemicals (EDCs) reprogram the epigenome to increase risk for hormone-dependent cancers and other diseases of adilthood

      ea0056s4.1
    • Iodine deficiency in pregnancy and development of offspring

      ea0056s4.2
    • Environmental contaminants and endocrine disruption: the story of obesogens

      ea0056s4.3
  • The role of sperm epigenome in fertility and inheritance
  • • The quality control of the male germline transcriptome

      ea0056s5.1
    • Abstract unavailable

      ea0056s5.2
    • Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms

      ea0056s5.3
  • Precision Medicine for diabetes (Endorsed by the European Journal of Endocrinology)
  • • Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?

      ea0056s6.1
    • Genetics can help to improve precision medicine in diabetes

      ea0056s6.2
    • Precision Nutrition in Obesity: gene-diet interactions

      ea0056s6.3
  • Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology)
  • • Triac: hormone, metabolite and drug.

      ea0056s7.1
    • Tetrac as an antiangiogenic agent in cancer

      ea0056s7.2
    • Thyroid hormones, metabolites, and analogs: Potential therapies for non-alcoholic fatty liver disease and other metabolic conditions

      ea0056s7.3
  • Bone fragility - from bench to clinic
  • • Clinical spectrum of new monogenic forms of osteoporosis

      ea0056s8.1
    • Abstract unavailable

      ea0056s8.2
    • Hypophosphatasia - diagnosis and treatment

      ea0056s8.3
  • EAA /ESE Session: Male gonadal function versus general health and vice versa
  • • Abstract unavailable

      ea0056s9.1
    • Klinefelter syndrome - a challenge for endocrinologists

      ea0056s9.2
    • Does 'healthy obesity' exist in andrology?

      ea0056s9.3
  • Hot topics in NETs
  • • Whole genome landscape in pancreatic neuroendocrine tumours

      ea0056s10.1
    • Abstract unavailable

      ea0056s10.2
    • Treatment update on carcinoid syndrome and carcinoid heart disease

      ea0056s10.3
  • Novel aspects of Craniopharyngioma
  • • Molecular pathogenensis of craniopharyngioma

      ea0056s11.1
    • Bariatric surgery as treatment in craniopharyngioma

      ea0056s11.2
    • The psychosocial, neuroendocrine and cognitive effects of childhood craniopharyngioma

      ea0056s11.3
  • Why do fractures occur in endocrine disorders, and how should they be handled?
  • • Abstract unavailable

      ea0056s12.1
    • Bone quality evaluation in Pituitary diseases

      ea0056s12.2
    • Parathyroid dysfunctions - bone mass and fractures in primary hyperparathyroidism

      ea0056s12.3
  • The colours of fat
  • • Brown adipose tissue as an endocrine organ

      ea0056s13.1
    • Adipose tissue browning in mice and men

      ea0056s13.2
    • Browning of adipose tissue in humans

      ea0056s13.3
  • Neuroendocrine basis of reproductive disorders
  • • Developmental wiring of GnRH neurons

      ea0056s14.1
    • Neuroendocrinology right from the nose: Genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)

      ea0056s14.2
    • Abstract unavailable

      ea0056s14.3
  • EYES: New aspects in the study of neuroendocrine diseases
  • • Introduction to EYES

      ea0056s15.1
    • Abstract unavailable

      ea0056s15.2
    • Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas

      ea0056s15.3
    • Abstract unavailable

      ea0056s15.4
    • Abstract unavailable

      ea0056s15.5
    • Abstract unavailable

      ea0056s15.6
  • Changing practice in the management of thyroid neoplasms
  • • New steps in the genomic alterations of thyroid malignancies

      ea0056s16.1
    • Composite approach in the evaluation and management of thyroid nodule

      ea0056s16.2
    • Abstract unavailable

      ea0056s16.3
  • Recent advances in Primary Adrenal Macronodular Hyperplasia
  • • Adrenal development and benign tumor formation

      ea0056s17.1
    • Genetics of Primary Bilateral Macronodular Adrenal Hyperplasia: when and what to test

      ea0056s17.2
    • Diagnosis and Management of Primary Adrenal Macronodular Hyperplasia

      ea0056s17.3
  • Borderline testosterone and metabolic outcomes among sexes: clinical relevance
  • • Sex hormones, obesity and type 2 diabetes-is there a link?

      ea0056s18.1
    • Relevant therapies in PCOS

      ea0056s18.2
    • Testosterone, obesity and the metabolic syndrome in males-do we need to replace steroids?

      ea0056s18.3
  • New Aspects of Pituitary Regulation
  • • Cytoskeleton, pharmacologic resistance and clinical aggressiveness in pituitary tumours

      ea0056s19.1
    • What fat does with your pituitary

      ea0056s19.2
    • How cancer treatment effects your pituitary

      ea0056s19.3
  • All you need to know about lipodystrophy (Endorsed by Endocrine Connections)
  • • Lipodystrophy as a model for prevalent insulin resistance

      ea0056s20.1
    • Acquired forms of lipodystrophy

      ea0056s20.2
    • Lipodystrophies, diagnosis and treatment: a step-by-step approach

      ea0056s20.3
  • The Dance of Adrenal and Gonads (Endorsed by Endocrine Connections)
  • • Abstract unavailable

      ea0056s21.1
    • Management of phaeochromocytoma during pregnancy

      ea0056s21.2
    • Fertility in Congenital Adrenal Hyperplasia

      ea0056s21.3
  • The fatty bone
  • • Abstract unavailable

      ea0056s22.1
    • Bone marrow adipose tissue: starving for attention

      ea0056s22.2
    • Cross-talk between bone marrow and peripheral adipose tissue in man

      ea0056s22.3
  • Pre-diabetes
  • • Abstract unavailable

      ea0056s23.1
    • Abstract unavailable

      ea0056s23.2
    • Treatment of Pre-Type 2 Diabetes

      ea0056s23.3
  • Ups and downs of hypothalamo-pituitary hormones
  • • How Does Pituitary Release its Hormones?

      ea0056s24.1
    • Peripheral activities of growth hormone-releasing hormone (GHRH)

      ea0056s24.2
    • The role of pituitary hormones (among others) in the generation of metabolic stress responses

      ea0056s24.3
  • Late Breaking
  • • Extracellular Vesicles: from waste-containers to new opportunities

      ea0056s25.1
    • Senescence-associated reprogramming promotes cancer stemness

      ea0056s25.2
    • LEAP2 is an Endogenous Antagonist of the Ghrelin Receptor

      ea0056s25.3
  • Cortisol: Too much of a Good Thing
  • • Genetics of Cushing's disease

      ea0056s26.1
    • Hypercortisolism and the brain

      ea0056s26.2
    • Differentiating Cushing from Pseudo-Cushing

      ea0056s26.3
  • Emerging treatments in osteoporosis
  • • Abstract unavailable

      ea0056s27.1
    • Novel therapies: PTH-related protein and sclerostin inhibition

      ea0056s27.2
    • Sequential and combination therapy for osteoporosis.

      ea0056s27.3
  • Endocrinology Meets Immunology
  • • Abstract unavailable

      ea0056s28.1
    • Abstract unavailable

      ea0056s28.2
    • Immunotherapy Related Endocrinopathies

      ea0056s28.3
  • Thyroid hormone action: regulation and clinical implications
  • • Tissue-specific regulation of thyroid hormone action

      ea0056s29.1
    • Thyroid hormone economy in human aging

      ea0056s29.2
    • Abstract unavailable

      ea0056s29.3
  • Disorders of Sexual Development (DSD)
  • • Abstract unavailable

      ea0056s30.1
    • Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery

      ea0056s30.2
    • Brain structure and function in gender dysphoria

      ea0056s30.3
  • Special Symposium: Bone & Vitamin D (Endorsed by Endocrine Connections)
  • • Free and bound vitamin D and health outcomes.

      ea0056ss1.1
    • Vitamin D in critical illness

      ea0056ss1.2
    • The effects of Vitamin D deficiency on macrophages function, cholesterol metabolism and cardiometabolic disease

      ea0056ss1.3
  • Guidelines: ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults
  • • ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults

      ea0056gl1.1
    • Abstract unavailable

      ea0056gl1.2
    • Abstract unavailable

      ea0056gl1.3
    • Abstract unavailable

      ea0056gl1.4
    • Abstract unavailable

      ea0056gl1.5
    • Abstract unavailable

      ea0056gl1.6
  • Endo-ERN: concrete examples of added value for patient care
  • • Introduction, structure, and virtual consultation using the EU-ERN CPMS

      ea0056ern1.1
    • Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism

      ea0056ern1.2
    • ESE Endo-ERN symposium: Patient and family perspectives, Manuela Brosamle, Endo-ERN ePAG

      ea0056ern1.3
• New Scientific Approaches
• • (1)
  • • Abstract unavailable

      ea0056nsa1
    • A comprehensive map of splicing alterations in small cell lung cancer

      ea0056nsa2
    • Reprgrammin strategies to obtain functional endocrine units; focus on the adrenal cortex

      ea0056nsa3
    • 3D visualisation of the HPG axis in mice and humans

      ea0056nsa4
    • Circulating miRNAs in endocrine tumours

      ea0056nsa5
    • Abstract unavailable

      ea0056nsa6
• Debates
• • Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats! (Endorsed by the European Journal of Endocrinology)
  • • Adrenal venous sampling vs imaging for primary aldosteronism

      ea0056d1.1
    • Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!

      ea0056d1.2
  • Receptor profiling is useful for predicting pituitary therapy (Endorsed by the European Journal of Endocrinology)
  • • Abstract unavailable

      ea0056d2.1
    • Abstract unavailable

      ea0056d2.2
  • Subclinical hypothyroidism is a disease
  • • FOR - subclinicl hypothyroidism is a disease

      ea0056d3.1
    • Abstract unavailable

      ea0056d3.2
  • AMH as the Primary Marker for Fertility
  • • AMH is the primary marker for fertility (Pro)

      ea0056d4.1
    • Debate: AMH as the primary marker for fertility

      ea0056d4.2
  • Pregnant women should be screened for thyroid hormones and antibodies
  • • Abstract unavailable

      ea0056d5.1
    • AGAINST: 'Pregnant women should be screened for thyroid hormones and antibodies'

      ea0056d5.2
  • Endocrine disruptors: Regulatory vs. Scientific Perspectives (Endorsed by Endocrine Connections)
  • • Abstract unavailable

      ea0056d6.1
    • Endocrine disruptors: Regulatory vs. Scientific Perspectives (regulatory view point)

      ea0056d6.2
• Meet the Expert Sessions
• • (1)
  • • Using diabetes technologies to improve patient self care

      ea0056mte1
    • Acromegaly: Optimal management after surgery

      ea0056mte2
    • Managing delayed puberty

      ea0056mte3
    • Osteoporosis in men: management of bone health in the endocrine outpatient clinic

      ea0056mte4
    • Medullary thyroid cancer beyond surgery

      ea0056mte5
    • Long-term implications of hypoglycaemia in diabetes Dr Ilhan Satman, Istanbul University, Turkey

      ea0056mte6
    • Difficult cases of differentiated thyroid cancer

      ea0056mte7
    • Hormone replacement for the travelling patient

      ea0056mte8
    • Premature ovarian insufficiency: an endocrine perspective

      ea0056mte9
    • The effect of gender-affirming therapy on bone in transgender persons

      ea0056mte10
    • How to integrate PCSK9 inhibitors into hyperlipidemia management

      ea0056mte11
    • Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?

      ea0056mte12
    • Erectile dysfunction

      ea0056mte13
    • Vitamin D for everybody?

      ea0056mte14
    • Your emergency consult about hyponatraemia

      ea0056mte15
    • Adrenal Incidentaloma

      ea0056mte16
    • Abstract unavailable

      ea0056mtbs1
    • Single-cell technologies in development and disease with a special emphasis on endocrine systems

      ea0056mtbs2
    • Watch out for noncanonical mechanisms of thyroid hormone action!

      ea0056mtbs3
• Nurse Sessions
• • (1)
  • • Abstract unavailable

      ea0056n1.1
    • Abstract unavailable

      ea0056n1.2
    • Abstract unavailable

      ea0056n1.3
    • Abstract unavailable

      ea0056n2.1
    • Abstract unavailable

      ea0056n2.2
    • Abstract unavailable

      ea0056n2.3
    • Abstract unavailable

      ea0056n2.4
    • Nursing Management of Congenital Adrenal Hyperplasia (CAH): - Education, Managment and use of Multi-Media Technology

      ea0056n3.1
    • Abstract unavailable

      ea0056n4.1
    • Abstract unavailable

      ea0056n4.2
    • Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance testing with two different doses (0.15 vs 0.10 U/kg)

      ea0056n4.3
    • Cooperation between an endocrine nurse, psychologist and physician and their role in the care of depression in patients treated with multi kinase inhibitors due thyroid cancer

      ea0056n4.4
    • Abstract unavailable

      ea0056n4.5
• Oral Communications
• • Benign thyroid diseases
  • • Familial gestational hyperthyroidism caused by Val597ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity

      ea0056oc1.1
    • Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications

      ea0056oc1.2
    • Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials

      ea0056oc1.3
    • The impact of obligatory iodine prophylaxis on thyroid volume in schoolchildren

      ea0056oc1.4
    • Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population

      ea0056oc1.5
  • Look who is controlling your gonads!
  • • The in vivo and in vitro effects of kisspeptin on human ovarian function

      ea0056oc2.1
    • Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation

      ea0056oc2.2
    • Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease

      ea0056oc2.3
    • Novel role of central ceramide signaling in mediating obesity-induced precocious puberty

      ea0056oc2.4
    • Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism

      ea0056oc2.5
  • New insights in bone disorders
  • • A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH)

      ea0056oc3.1
    • Can a bone protein protect against muscular dystrophy?

      ea0056oc3.2
    • [18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue

      ea0056oc3.3
    • Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy

      ea0056oc3.4
    • Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen

      ea0056oc3.5
  • Novel insights into prediabetes and type 2 diabetes
  • • Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications

      ea0056oc4.1
    • Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes

      ea0056oc4.2
    • Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy

      ea0056oc4.3
    • Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial

      ea0056oc4.4
    • The impact of prediabetes in lung function: data from the ILERVAS project

      ea0056oc4.5
  • Diving deep into adrenal cortex diseases
  • • Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study

      ea0056oc5.1
    • Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas

      ea0056oc5.2
    • PRKACA L206R mutation in adrenal Cushing's syndrome makes PKA RII[beta] susceptible for caspase-mediated cleavage

      ea0056oc5.3
    • Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency - a Pilot Study

      ea0056oc5.4
    • Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia

      ea0056oc5.5
  • Genetic and environmental determinants of obesity and insulin resistance
  • • 5[beta]-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism in vitro and in vivo

      ea0056oc6.1
    • Deep transcranial magnetic stimulation acutely modulates neuro-endocrine pathways underlying obesity

      ea0056oc6.2
    • Visceral fat assessment in lamin A/C mutation carriers: phenotype -genotype correlation

      ea0056oc6.3
    • Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users

      ea0056oc6.4
    • Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations

      ea0056oc6.5
  • Genomic and clinical aspects of endocrine tumours
  • • Molecular classification of benign adrenocortical tumors: an integrated genomic study

      ea0056oc7.1
    • Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy - a prospective test validation study

      ea0056oc7.2
    • LncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor

      ea0056oc7.3
    • Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas

      ea0056oc7.4
    • Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)

      ea0056oc7.5
  • MicroRNAs as biomarkers in endocrine diseases
  • • Plasma microRNA expression in patients with Cushing's disease differs from ACTH-ectopic Cushing's syndrome

      ea0056oc8.1
    • MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease

      ea0056oc8.2
    • Circulating levels of microRNAs associate with blood pressure and left ventricular mass in primary hypertensive patients

      ea0056oc8.3
    • Detecting blood micro-RNAs and proteins associated with Graves' disease and orbitopathy

      ea0056oc8.4
    • MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures

      ea0056oc8.5
  • Thyroid from basics to clinics
  • • Increased urinary iodide precedes hypothyroidism in Dehal1 knockout mice

      ea0056oc9.1
    • Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer

      ea0056oc9.2
    • A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions

      ea0056oc9.3
    • Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer

      ea0056oc9.4
    • Sentinel lymph node biopsy using methylene blue dye in papillary and medullary thyroid carcinomas and microcarcinomas in decision for lateral neck dissection

      ea0056oc9.5
  • Cardiovascular aspects of endocrine diseases
  • • Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison's disease - a population based retrospective cohort study

      ea0056oc10.1
    • Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice

      ea0056oc10.2
    • ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study

      ea0056oc10.3
    • Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism

      ea0056oc10.4
    • Increased risk of antithyroid drug-induced agranulocytosis with amiodarone

      ea0056oc10.5
  • Clinical practice in endocrine tumours: combining conventional and molecular features
  • • Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication

      ea0056oc11.1
    • Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma

      ea0056oc11.2
    • Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients

      ea0056oc11.3
    • Update in the genetic landscape of Cushing's Disease: TP53 and a new deubiquitinase in spotlight

      ea0056oc11.4
    • Natural history of Rathke's Cleft Cysts: a multicenter experience

      ea0056oc11.5
  • Novel aspects of puberty development and Cushing's disease
  • • Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty

      ea0056oc12.1
    • Oligogenicity in Kallmann syndrome - an underestimated phenomenon?

      ea0056oc12.2
    • Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism

      ea0056oc12.3
    • Late-night salivary cortisol (LNSC) levels in a Phase III study of long-acting pasireotide in patients with Cushing's disease (CD)

      ea0056oc12.4
    • Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN

      ea0056oc12.5
  • The curious case of growth hormone
  • • Postoperative use of somatostatin analogs and mortality in patients with acromegaly

      ea0056oc13.1
    • Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma

      ea0056oc13.2
    • Molecular profiling for assistance to pharmacological treatment of acromegaly

      ea0056oc13.3
    • Effects of pegvisomant on glucose metabolism in acromegaly: A meta-analysis of prospective interventional studies

      ea0056oc13.4
    • Growth hormone acts in AgRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus

      ea0056oc13.5
  • What is new in gestational and type 1 diabetes?
  • • Does insulin treatment differ in their impact on placental vascular circulation in obese and non obese women with gestational diabetes mellitus?

      ea0056oc14.1
    • Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus

      ea0056oc14.2
    • Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis

      ea0056oc14.3
    • The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus

      ea0056oc14.4
    • Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine

      ea0056oc14.5
• Guided Posters
• • Acromegaly
  • • Retinal vessel abnormalities in acromegaly

      ea0056gp2
    • An insight into the putative risk factors for IGF-1/GH dichotomy during follow-up for acromegaly

      ea0056gp3
    • Efficacy and safety of switching to pasireotide LAR monotherapy or in combination with pegvisomant in acromegaly patients controlled with combination therapy of somatostatin analogues and pegvisomant (PAPE study): a prospective, open-label 48 week study

      ea0056gp4
    • The importance of MEN1 gene variants in AIP mutation negative FIPA patients

      ea0056gp5
    • IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression

      ea0056gp6
    • Familial cancer clustering in patients with pituitary adenoma

      ea0056gp7
    • ACRONIS, a European observational study in patients with uncontrolled acromegaly who are being treated with long acting pasireotide: first interim analysis

      ea0056gp8
    • Pregnancy and acromegaly - clinical outcomes from the Irish Pituitary Network

      ea0056gp9
    • Human growth hormone (GH) isoforms during oral glucose tolerance test in patients with acromegaly and in healthy subjects

      ea0056gp10
    • Observational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL study

      ea0056gp11
    • Cumulative effects of growth hormone and insulin-like growth factor-1 exposure on cardiovascular, cerebrovascular and metabolic co-morbidities in acromegaly patients

      ea0056gp12
  • Adrenal Case reports
  • • Adrenal schwannoma presenting as an adrenal incidentaloma in a pregnant woman

      ea0056gp13
    • Sporadic paraganglioma and the importance of genetic screening

      ea0056gp14
    • Etomidate for the management of severe hypercortisolaemia in different clinical scenarios - a case series

      ea0056gp15
    • Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the FH gene

      ea0056gp16
    • A rare cause of endocrine hypertension

      ea0056gp17
    • Bilateral testicular masses and adrenal insufficiency in a young adult: is congenital adrenal hyperplasia the only possible diagnosis?

      ea0056gp18
    • Nonclassical congenital adrenal hyperplasia in a young patient with Type 1a Glycogen storage disease: is there a novel link between glucose metabolism and adrenal steroidogenesis?

      ea0056gp19
    • Cushing's syndrome revealing carney complex due to novel PRKAR1A mutation

      ea0056gp20
    • The importance of the follow-up after bilateral adrenal adenomectomy for Cushing's syndrome

      ea0056gp21
  • Adrenal clinical
  • • Hypoadrenalism in advanced HIV: a pilot study

      ea0056gp22
    • Nicotinamide Nucleotide Transhydrogenase as a novel treatment target in adrenocortical carcinoma

      ea0056gp23
    • Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study

      ea0056gp24
    • Metabolic fingerprints after Cushing syndrome cure

      ea0056gp25
    • Segmental adrenal venous sampling may give a key to solution about the debate of cosyntropin stimulation or not

      ea0056gp26
    • The short synacthen test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function and guide clinical practice

      ea0056gp27
    • Immunohistochemical staining for histopathological subclassification of primary aldosteronism: nationwide 10-year results from Iceland

      ea0056gp28
    • Salivary cortisol and cortisone in Cushing diagnosis - reference ranges and clinical cut off limits

      ea0056gp29
    • The urinary cortisol metabolome in patients with adrenal insufficiency: dual-release hydrocortisone is less deleterious than conventional hydrocortisone therapy

      ea0056gp30
    • Circular RNA circ0066659 functions as a competitive endogenous RNA by sponging miR-506-3p in adrenocortical carcinoma

      ea0056gp31
  • Adrenal cortex
  • • PRKACA L206R mutation in adrenal Cushing induces histone H1.4 hyper-phosphorylation

      ea0056gp32
    • Alterations in Clock genes expression in human benign adrenal tumors

      ea0056gp33
    • Effects of replication of the physiological and non-physiological cortisol rhythm on insulin sensitivity in muscle: a molecular in vitro analysis on synchronized muscular cells

      ea0056gp34
    • The circadian rhythm of glucocorticoid administration entrains clock-controlled genes in blood mononuclear cells: a DREAM trial ancillary study

      ea0056gp35
    • Identification of new ARMC5 missense mutations in Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) and their functional studies in vitro

      ea0056gp36
    • MicroRNA expression profiling in adrenal myelolipoma, adrenocortical cancer and adrenocortical adenoma

      ea0056gp37
    • Identification of a new target of PRKAR1A (Carney complex gene): KCTD20 (potassium channel tetramerization domain containing 20) and study of its role in adrenal Cushing

      ea0056gp38
    • Gene mutation analysis and overal survival among the patints with neuroendocrine tumors of the lung and gastroenteropancreatic neuroendocrine tumors

      ea0056gp39
    • Long term imaging follow-up of non-functioning adrenal adenomas at Vilnius University Hospital Santaros Klinikos (VUHSK): 2010-2017

      ea0056gp40
    • The need for depression screening in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion - the role of integrated care

      ea0056gp41
  • Adrenal medulla and NETs
  • • Pituitary adenoma and pheochromocytoma/paraganglioma: a multicausal association of tumors

      ea0056gp42
    • Ex vivo metabolomic profiling in phaeochromocytoma, paraganglioma and GIST tumours: lessons learned

      ea0056gp43
    • Mortality in patients with Pheochromocytoma: a population-based study 1977-2016

      ea0056gp44
    • The 10 Hounsfield Units cut-off value on unenhanced CT imaging is highly sensitive to diagnose pheochromocytoma: a multicenter study

      ea0056gp45
    • Comparative study between incidental and symptomatic pheochromocytoma

      ea0056gp46
    • Identifying active steroids, steroid receptors and pathways in the normal breast and their potential relationship to obesity and cancer development

      ea0056gp47
    • In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer

      ea0056gp48
    • Targeted destruction of FSHR-positive cancer cells by a lytic Phor21-FSHb conjugate

      ea0056gp49
    • Abstract unavailable

      ea0056gp50
    • Evolution of mesenteric metastasis in small intestinal neuroendocrine tumours (SI-NETs)

      ea0056gp51
    • Epidemiology and clinical significance of clinical hormonal syndromes in patients with neuroendocrine tumors

      ea0056gp52
  • Bone and Osteoporosis
  • • Online bots could help in prevention and treatment of osteoporosis

      ea0056gp53
    • Effect of inhaled corticosteroidson trabecular bone score in patients with asthma

      ea0056gp54
    • Association between diabetes and the risk of falls: a nationwide population-based study

      ea0056gp55
    • The influence of adipose tissue and bone marrow fat on bone mineral density in short bowel syndrome

      ea0056gp56
    • Kinesiotherapy rehabilitation program to correct deep core stability muscle dysfunction in patients with osteoporotic vertebral fractures

      ea0056gp57
    • Investigating glucocorticoids as mediators of increased bone marrow adiposity during caloric restriction

      ea0056gp58
    • Thirty-one men and women with145 spontaneous vertebral fractures after denosumab discontinuation: a single center observational study

      ea0056gp59
    • Effects of anti-osteoporotic medications on glucose metabolism and the incidence of type 2 diabetes mellitus: a systematic review

      ea0056gp60
    • Bone structural components and lean mass assessed by 3D-DXA in hip fracture patients

      ea0056gp61
    • Inflammatory profile in monocytes of patients with Addison's disease and Vitamin D effects

      ea0056gp62
  • Cardiovascular
  • • OCT1 gene variants are associated with cardiovascular characteristics in non-diabetic, prediabetic and diabetic patients

      ea0056gp63
    • Habitual dietary intake of n-3 polyunsaturated fatty acids and leptin gene expression in visceral and subcutaneous adipose tissues of non-diabetic adults

      ea0056gp64
    • Decreased heart rate variability can predict future development of metabolic syndrome in Asian adults

      ea0056gp65
    • Evaluation of irisin levels in chronic heart failure with preserved or reduced ejection fraction

      ea0056gp66
    • Liraglutide prevented the deposition of Collagen in the animal model of Bleomycin-induced lung fibrosis

      ea0056gp67
    • Turner syndrome and cardiovascular risk

      ea0056gp68
    • Can monogenic severe hypertriglyceridemia be differentiated from polygenic forms through clinical features: data from APPROACH and COMPASS studies in FCS and non-FCS hypertriglyceridemic patients?

      ea0056gp69
    • Changes in lipid profile 5 years after bariatric surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy

      ea0056gp70
  • Diabetes Complications
  • • Prevalence and risk factors of periodontitis in diabetic patients with or without metabolic syndrome

      ea0056gp71
    • Toe-brachial index is associated more strongly with progression of diabetic nephropathy than ankle-brachial index in type 2 diabetic patients

      ea0056gp72
    • The BMI and skeletal muscle mass as a risk factor of carotid atherosclerosis in patients with type 2 diabetes

      ea0056gp73
    • Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?

      ea0056gp74
    • Effects of post-transplant and pre-existing diabetes mellitus on graft function after kidney transplantation

      ea0056gp75
    • Glucose variability and pregnancy outcomes in gestational diabetes mellitus: a prospective study

      ea0056gp76
    • Patients with community acquired pneumonia are three times more likely to die if they have concomitant diabetes mellitus

      ea0056gp77
    • Diabetic patients are old as theirs feet are old:the strongest association of foot pathology with mortality in diabetes

      ea0056gp78
    • Outcomes of hyperglycemia in patients with and without diabetes mellitus hospitalized for infectious diseases

      ea0056gp79
    • Self-reported low-energy fractures and associated risk factors in diabetic portuguese patients: a cross-sectional population-based study

      ea0056gp80
    • Impaired cortisol and growth hormone counterregulatory responses during severe hypoglycemia in type 2 diabetes mellitus

      ea0056gp81
  • Diabetes Epidemiology
  • • Maternal exposure to air pollutants and risk of gestational diabetes mellitus in Taiwan

      ea0056gp82
    • Prevalence and predictors of gestational diabetes mellitus: a nationwide multicenter prospective study

      ea0056gp83
    • Incretin hormones in pathogenesis of secondary hyperglycaemia in patients with Cushing's disease and acromegaly

      ea0056gp84
    • Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

      ea0056gp85
    • Heart rate variability is related to concomitant glucose fluctuation in longstanding type 1 diabetes

      ea0056gp86
    • Differential expression of apoptotic and low grade inflammatory markers in Alzheimer's disease compared to diabetes mellitus type 1 and 2

      ea0056gp87
    • Gestational diabetes mellitus and continuous glucose monitoring system. A prospective study.

      ea0056gp88
    • Depression screening in adults with diabetes

      ea0056gp89
    • Nutritional composition of carbohydrate-rich gluten free products and glycemic index calculation of commercially available gluten free pasta

      ea0056gp90
    • Analysis of health-related quality of life in patients with type 2 diabetes mellitus: results of an epidemiological study FORSIGHT-T2DM

      ea0056gp91
    • Gestational Diabetes Mellitus is associated with increased risk of Non-Alcoholic Fatty Liver Disease: A population-based cohort study

      ea0056gp92
  • Diabetes Therapy
  • • Proinflammatory cytokines and endotoxemia level change in patients with type 2 diabetes and nonalcoholic fatty liver disease after hepatoprotective and probiotic therapy usage

      ea0056gp93
    • Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-center Randomized Controlled Trial

      ea0056gp94
    • Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study

      ea0056gp95
    • Long term results and determinants of outcomes in primary health care diabetes prevention. The DE-PLAN project

      ea0056gp96
    • Comparison of insulin degludec with Insulin glargin 300 units/ml in insulin-naive patients with type 2 diabetes mellitus

      ea0056gp97
    • Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation

      ea0056gp98
    • Optimal time for measuringglucose level to detect steroid induced hyperglycaemia

      ea0056gp99
    • Effect of aerobic exercise training on serum malondialdehyde level and quality of life in type 2 diabetes

      ea0056gp100
    • A healthier fat intake is associated with absence of diabetic retinopathy in patients with type 1 diabetes

      ea0056gp101
    • Type 2 diabetes remission one year after bariatric surgery - a comparison between vertical sleeve gastrectomy and gastric bypass

      ea0056gp102
    • Glycemic control and outcomes of patients admitted in the acute stroke unit

      ea0056gp103
    • Validation of Friedewald formula for estimatinglow-density lipoprotein cholesterol in Korea: the Korea National Health and Nutrition Examination Survey, 2009-2011

      ea0056gp104
  • Diabetes Translational
  • • Acute insulin-induced hypoglycemia decreases systemic fibrinolytic balance in patients with type 1 diabetes

      ea0056gp105
    • Transcranial duplexsonography in patients with type 1 diabetes and diabetic nephropathy

      ea0056gp106
    • Cumulative effect of glucose regulation in Calbindin-D9k knockout mice

      ea0056gp107
    • The effect of GLP-1 agonist treatment on serum betatrophin levels and comparison with insulin treatment in type 2 diabetes mellitus patients

      ea0056gp108
    • High glucose stimulates mineralocorticoid receptor activity of retinal Muller glia cell

      ea0056gp109
    • Knock-down of class 2a histone deacetylases (HDACs) in hepatocytes of healthy mice does not affect gluconeogenesis but is associated with increased hematopoiesis

      ea0056gp110
    • Olfactory receptor OR51E1 mediates GLP-1 secretion in enteroendocrine L cells

      ea0056gp111
    • Study on antioxidant and hypoglycemic effects of natural polyphenols in the experimental diabetes model

      ea0056gp112
    • Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo

      ea0056gp113
    • Benefits of the association of triiodothyronine (T3) to insulin treatment for the glycemic control of alloxan-induced diabetic rats

      ea0056gp114
    • Male AKR1D1 (5[beta]-reductase) knockout mice have altered pancreatic islet morphology and hormone secretion

      ea0056gp115
    • The role of oncostatin m in the development of type 2 diabetes associated with obesity

      ea0056gp116
  • Endocrine Case Reports
  • • A rare case report of Graves disease with coexisting TSH producing pituitary adenoma

      ea0056gp117
    • Abstract unavailable

      ea0056gp118
    • Non-syndromic multiple insulinomas with atypical clinico-biological presentation in two adult patients: a specific entity?

      ea0056gp119
    • Langerhans cell histiocytosis: diagnosis on thyroid aspirate

      ea0056gp120
    • Coexistence of papillary thyroid cancer and malignancies of other organs in patients carrying CHEK2 gene mutations - case series.

      ea0056gp121
    • A case of nivolumab induced fulminant type 1 diabetes

      ea0056gp122
    • A rare case of type-2 familial partial lipodystrophy (FLD type 2) non-Dunnigan type with laminin A/C gene (LMNA) mutation causing multi-organ failure and diabetes mellitus

      ea0056gp123
    • MODY - a diagnosis to be considered in diabetes

      ea0056gp124
    • Hyperinsulinaemic hypoglycaemia in the three generations of a family with GCK, c.295T>C (p.Trp99Arg) mutation

      ea0056gp125
    • Acromegaly and acromegaloidism, two rare insulin-resistance conditions in one patient: reason for GH-IGF-1 discrepancy?

      ea0056gp126
  • Female Reproduction
  • • Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

      ea0056gp127
    • Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines

      ea0056gp128
    • Impaired GLP-1 response predicts prediabetes in obese PCOS with adverse metabolic phenotype independent of BMI

      ea0056gp129
    • Alterations in gonadotropin receptors and signal activation in granulosa lutein cells from women with polycystic ovary syndrome

      ea0056gp130
    • Prevalence of mutations in the insulin receptor gene and lamin A/C gene in functional ovarian hyperandrogenism with insulin resistance

      ea0056gp131
    • Women with PCOS display reduced cardiac vagal activity which is dependent on metabolic abnormalities

      ea0056gp132
    • Favorable prognosis of pregnancies in 28 hypopituitary women: Retrospective multicentric study on 39 pregnancies

      ea0056gp133
    • Abstract unavailable

      ea0056gp134
    • Liquid chromatography-tandem mass spectrometry characterization of a broad serum and salivary steroid profile in classical form of polycystic ovary syndrome

      ea0056gp135
    • Novel mechanisms and genes involved in the pathogenesis of primary ovarian insufficiency (POI) by whole-exome sequencing approach

      ea0056gp136
    • Hypothalamo-pituitary-adrenal axis sensitivity in women with polycystic ovary syndrome

      ea0056gp137
  • Neuroendocrinology
  • • Hypermethylation of tumour suppressor genes in pituitary adenomas: contribution to oncogenesis and tumour behaviour

      ea0056gp138
    • Why don't corticotroph tumours always produce Cushing disease?

      ea0056gp139
    • New horizons in medical treatment of Bronchial Carcinoids: evidence from in vitro models

      ea0056gp140
    • Reproductive and metabolic consequences of AMP-Activated Protein Kinase (AMPK) ablation in GnRH neurons

      ea0056gp141
    • Preoperative SSA treatment positively affects the outcome of pituitary neurosurgery in acromegaly patients

      ea0056gp142
    • Characterization and functional rescue of a nephrogenic diabetes insipidus causing S127F substitution in V2 vasopressin receptor

      ea0056gp143
    • Genetics of binge-eating disorder (BED): a pilot study

      ea0056gp144
    • Hyponatremia-associated mortality and volemia in patients on parenteral nutrition: a prospective multicenter study

      ea0056gp145
    • Hyperglycemia causes a reduction in FSH levels following aberrant epigenetic regulation in the gonadotropes due to the increased glucose metabolism

      ea0056gp146
    • Macrophages involvement in neuroendocrine tumor behaviour and progression

      ea0056gp147
    • Mountain cycling ultramarathon effects on neuromuscular, immune and stress biomarkers

      ea0056gp148
  • Obesity
  • • Sex hormone-binding globulin is more than a sex steroid carrier: a New therapeutic target against obesity and non-alcoholic fatty liver disease

      ea0056gp149
    • Use of ultrasonography as a simple diagnostic method to measure different abdominal fat layers and metabolic syndromeprediction

      ea0056gp150
    • Improvement in insulin-mediated suppression of branched-chain amino acid flux is responsible for the post-bariatric surgery decrease in plasma branched-chain amino acid levels

      ea0056gp151
    • Cell-derived extracellular vesicles as important intercellular messengers in obesity

      ea0056gp152
    • How to better predict weight loss and type 2 diabetes remission after bariatric surgery? the potential role of genetic scoring systems in clinical practice

      ea0056gp153
    • Eating and substance-related disorders after bariatric surgery

      ea0056gp154
    • Changes in gut microbiota and metabolic profiles after sleeve gastrectomy

      ea0056gp155
    • Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

      ea0056gp156
    • Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin

      ea0056gp157
    • Dietary intake of fat and oil are associated with expression of miR-143 and miR-34a in visceral and subcutaneous adipose tissues of adults: a nutriepigenetic study

      ea0056gp158
    • Role of Elovl6 in the thermogenic action of brown and beige adipocyte during [beta]3-adrenergic receptor activation

      ea0056gp159
    • Physiological regulation of brown adipose tissue in obesity by mild-cold exposure, a B3-agonist and exercise training at thermoneutrality

      ea0056gp160
    • Cold induced thermogenesis is influenced by seasonal changes in outdoor temperature

      ea0056gp161
  • Paediatrics, Developmental ' Female Reproduction
  • • Biomonitoring infantile urinary sexual hormone profiles for investigation of the endocrine disruptors associated mini-puberty effects

      ea0056gp162
    • Global DNA methylation since early infancy to adulthood in the offspring of women with polycystic ovary syndrome (PCOS)

      ea0056gp163
    • Utilisation of dental services and dental pathologies identified in children and adolescents with osteogenesis imperfecta in the south west of England

      ea0056gp164
    • Early childhood BMI rise, the adiposity rebound, associates with PCOS diagnosis and obesity at ages 31 and 46 years - analysis of 46-year growth data from birth to adulthood in PCOS

      ea0056gp165
    • Endemic goiter and breasts diseases in adolescent girls

      ea0056gp166
    • Impact of fetal exposure to testosterone on fetal insulin sensitivity tissues in female sheep: a morphological and molecular approach

      ea0056gp167
    • Self-esteem, emotional stability, social anxiety disorder and suicidal behaviours among transgender youth before gender-affirmative treatment in spain

      ea0056gp168
    • Glucose transporters in human placenta and its relation to birth weight

      ea0056gp169
    • Association of glucocorticoid receptor gene (NR3C1) expression in HUVECs with glycemic targets during gestational diabetes treatment: a pilot randomized controlled study

      ea0056gp170
    • Autoimmunity markers in turner syndrome patients

      ea0056gp171
  • Parathyroid
  • • A pilot study of the differences in miRNA expression profile in the blood serum between patients with malignant and benign parathyroid tumors

      ea0056gp172
    • Excess of parathyroid hyperplasia incidence in subjects exposed to ionizing radiation after the CHNPP accident

      ea0056gp173
    • The design and preliminary results of a phase 1 TransCon PTH trial in healthy volunteers

      ea0056gp174
    • Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement

      ea0056gp175
    • Symptom burden and HRQoL reported among patients with chronic hypoparathyroidism: impact of treatment with rhPTH (1-84) and with standard therapy

      ea0056gp176
    • Maintenance of key biochemical parameters with recombinant human parathyroid hormone (1-84) in patients with hypoparathyroidism: an analysis of a long-term, open-label, single-centre study

      ea0056gp177
    • The global, prospective, observational PARADIGHM™ registry for patients with chronic hypoparathyroidism was expanded to capture recombinant human parathyroid hormone, rhPTH(1-84), use under routine clinical care

      ea0056gp178
    • Stone risk profile analysis in patients with asymptomatic primary hyperparathyroidism

      ea0056gp179
    • Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study

      ea0056gp180
    • Is there HIV-associated hypoparathyroidism?

      ea0056gp181
    • Use of a Disease-Characteristic Questionnaire identified pain and cramps and neuro-vegetative symptoms as significantly elevated and affected by Medication in mainly well-controlled hypoparathyroid patients

      ea0056gp182
    • A novel mutation in the calcium sensing receptor GENE IN AN Italian family affected by autosomal dominant hypocalcemia

      ea0056gp183
  • Pituitary / Growth Hormone ' IGF Axis
  • • Adrenal insufficiency induced by anti-PD-1/anti-PD-L1 therapy in patients with cancer: a series of cases

      ea0056gp184
    • Long-term treatment with metyrapone in four patients with Cushing's disease

      ea0056gp185
    • Primary posterior pituitary tumors: a unique neoplasm with hight morbidity

      ea0056gp186
    • Erdheim-chester disease presenting with hypopituitarism and diabetes insipidus

      ea0056gp187
    • Growth disorders in paediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning- the experience of a single center

      ea0056gp188
    • Association of IGF1 receptor autoantibodies with height and body size

      ea0056gp189
    • Insulin sensitivity improves after disease control in acromegaly irrespective of treatment modality and despite an increase in intrahepatic lipid content: data from an investigator-initiated prospective trial

      ea0056gp190
    • Ectopic Cushing's syndrome secondary to medullary thyroid carcinoma with apparent signs of hypercortisolism: a case report

      ea0056gp191
    • A case series of endocrine immune-related adverse effects of checkpoint inhibitors

      ea0056gp192
    • Hypophysitis due to immune checkpoint blockade: rising numbers.

      ea0056gp193
  • Pituitary Basic
  • • Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs

      ea0056gp194
    • Filamin A (FLNA) phosphorylation inhibits SSTR2 signal transduction in GH-secreting pituitary tumor cells

      ea0056gp195
    • E-cadherin expression is associated with the response to somatostatin analogues in patients with acromegaly

      ea0056gp196
    • Efficacy of pharmacological USP8 inhibition in human Cushing's disease tumours in vitro

      ea0056gp197
    • Ubiquitin specific peptidase 8 (USP8) in human corticotroph pituitary tumors- possible targets and mode of action

      ea0056gp198
    • Prominent expression of MAX and MEG3, despite lack of mutations in MAX, suggest a potential role for 14q genes in pituitary adenomas

      ea0056gp199
    • Pharmacological characterization of somatostatin receptor subtype 3 as a potential strategy to treat non-functioning pituitary adenomas

      ea0056gp200
    • Epigenetic and post-transcriptional regulation of the SSTR5 gene in somatotropinomas

      ea0056gp201
  • Pituitary Clinical
  • • Endoscopic vs microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis

      ea0056gp202
    • Factors predicting comorbidities in cured patients with Cushing's syndrome

      ea0056gp203
    • Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study

      ea0056gp204
    • Predictors of response to long-acting pasireotide in patients with Cushing's disease during a Phase III study

      ea0056gp205
    • Clinicopathological correlations in pituitary thyrotroph tumors from a cohort of 23 patients

      ea0056gp206
    • Molecular profiling of non-functioning pituitary adenomas does not support pharmacological therapeutic options

      ea0056gp207
    • The role of clomiphene citrate in the resolution of hypogonadism in male patients with prolactinomas under cabergoline therapy

      ea0056gp208
    • Cabergoline - therapy for 121 giant invasive prolactinomas

      ea0056gp209
    • Endocrine disorders in adults after allogenic hematopoietic stem cell transplant

      ea0056gp210
    • A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors

      ea0056gp211
    • Predictors of failure to respond to fluid restriction and furosemide efficacy prediction in patients presenting Syndrome of Inappropriate Antidiuretic while receiving parenteral nutrition. Prospective Multicenter Study

      ea0056gp212
    • Abstract unavailable

      ea0056gp213
  • Reproduction
  • • Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management

      ea0056gp214
    • Alleviation of perfluorooctanesulfonate (PFOS)-induced disruption of blood-testis barrier by altering cell signaling molecule expression in human sertoli cells.

      ea0056gp215
    • Sertoli cell-specific knockout of coxsackie and adenovirus receptor (Cxadr) disrupts the blood-testis barrier and causes impaired fertility

      ea0056gp216
    • The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH): genetic and brain abnormalities

      ea0056gp217
    • Bioassay-based characterization of novel androgens

      ea0056gp218
    • Mitochondrial phenotype of FOXL2 variants associated with Blepharophimosis, Ptosis and Epicantus Inversus Syndrome (BPES)

      ea0056gp219
    • Depletion of the primate-specific luteinizing-hormone receptor splice variant 'exon-6A' impairs LH-, but not hCG-mediated signaling in human primary granulosa cells

      ea0056gp220
    • The value of androstenedione and DHEA-S levels in diagnosis of polycystic ovary syndrome in young women

      ea0056gp221
    • Change in visceral fat and its relation with change in lipids in trans persons during hormonal therapy: results from a multicenter prospective study

      ea0056gp222
    • GHR ablation in the brain or in leptin receptor expressing cells causes metabolic effects during pregnancy

      ea0056gp223
  • Thyroid Cancer - Diagnostics & Treatments
  • • Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer

      ea0056gp224
    • Germline mutations in KIF1B gene in two families with familial non-medullary thyroid cancer (FNMTC)

      ea0056gp225
    • Significant acceleration in dynamics of medullary thyroid cancer markers concentration - report of 26 cases

      ea0056gp226
    • The adverse effect of radioactive iodine therapy on bone marrow for differentiated thyroid cancer patients

      ea0056gp227
    • Familial non-medullary thyroid carcinoma. Are we facing a different entity?

      ea0056gp228
    • Is thyroid nodule size a factor to consider when deciding for fine-needle aspiration procedure?

      ea0056gp229
    • Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

      ea0056gp230
    • Related recurrence factors in a Spanish cohort of differentiated thyroid carcinoma. Cadit-CAM Study

      ea0056gp231
    • Imaging in clinical research devoted to medullary thyroid carcinoma: a systematic meta-analysis

      ea0056gp232
    • Molecular profiling of a large papillary thyroid cancer series followed at a single center: data on mutation density, heterogeneity and phenotype-genotype correlations

      ea0056gp233
    • Title Evaluation of the CCK-2-receptor agonist 177Lu-PP-F11N for peptide receptor radionuclide therapy (PRRT) of medullary thyroid carcinoma - First results of a phase 0 'Lumed' Study

      ea0056gp234
    • Does body mass index influence the clinical stage, treatment response and course of the disease in patients with differentiated thyroid cancer?

      ea0056gp235
  • Thyroid Cancer - Translational
  • • Neural stem cells expressing cytosine deaminase and interferon-[beta] suppressed the growth and metastasis of anaplastic thyroid cancer cells

      ea0056gp236
    • Comparison in survival of the seventh and eighth editions of the American Joint Commision on Cancer in a Spanish cohort of differentiated thyroid carcinoma: Cadit-CAM Study

      ea0056gp237
    • Carrying mutations truncating CHEK2 protein predisposes to thyroid neoplasms - preliminary report

      ea0056gp238
    • The capability of the Bethesda System Reporting for Thyroid Cytopathology (TBSRTC) in identifying of thyroid carcinoma

      ea0056gp239
    • Orthotopic PDX Mouse Model of humanprimary Undifferentiated/Anaplastic thyroid carcinoma

      ea0056gp240
    • Detection of lncRNAs in thyroid nodule as new tool for tumor diagnosis: analysis by Droplet Digital PCR in Fine Needle Aspiration biopsy

      ea0056gp241
    • New markers of follicular thyroid cancer found with wide-panel next-generation sequencing

      ea0056gp242
    • Prognostic value of N0 classification in differentiated thyroid cancer

      ea0056gp243
    • Implementation of the British Thyroid Association thyroid nodule classification: a general UK hospital perspective

      ea0056gp244
    • Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer

      ea0056gp245
  • Thyroid non cancer
  • • Genistein Increase Thyroid Hormone and 7 alpha-hydroxycholesterol concentrations in the liver of middle-aged male rats

      ea0056gp246
    • Serum FT4 levels predict incidence of type 2 diabetes and cardiovascular disease in the general population

      ea0056gp247
    • Thyroid function in early-treated adult PKU patients

      ea0056gp248
    • Abnormal thyroid enzymes in critically ill patients with no known prior thyroid disorder are an independent predictor of mortality

      ea0056gp249
    • Assessment of carotid intima-media thickness and endothelial dysfunction in patients with hypothyroidism

      ea0056gp250
    • Thyroid-specific mitochondrial dysfunction results in abnormal thyrotropin responses

      ea0056gp251
    • T3 enhances GLUT2, PEPT1 and CD36/SR-B2 content in the intestinal epithelium of mice

      ea0056gp252
    • Identification of new thyroid hormone dependent biomarkers for a successful replacement therapy

      ea0056gp253
    • Proteome analysis of 3,5-T2-treated primary mouse hepatocytes

      ea0056gp254
  • Thyroid non cancer - Autoimmune Thyroid disease/pregnancy
  • • MicroRNA-4443 causes CD4+T cells dysfunction by targeting TRAF4 in Graves' disease

      ea0056gp255
    • Are Thyrotropin Receptor Antibodies (TRAb) being used to diagnose the aetiology of hyperthyroidism?

      ea0056gp256
    • Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value

      ea0056gp257
    • Influence of levothyroxine treatment in pregnant women with thyroid antiperoxidase antibodies

      ea0056gp258
    • Thyroid disorders in patients with advanced neoplastic disease treated with immune checkpoints inhibitors

      ea0056gp259
    • Early low dose rituximab for active thyroid eye disease: an effective and well tolerated treatment

      ea0056gp260
    • Analysis of serum immunoglobulin G4 (IgG4) levels in euthyroid subjects with autoimmune thyroid disease and goiter in a Single Medical Center in Taiwan

      ea0056gp261
    • Thyroid disorders in patients treated with inmune checkpoint inhibition therapy

      ea0056gp262
    • Thyroid peroxidase antibody-positivity, but not isolated thyroglobulin antibody-positivity, is associated with non-thyroidal autoimmune diseases - a population study of more than 8000 Danes

      ea0056gp263
    • Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)

      ea0056gp264
  • Thyroid non cancer - Benign Thyroid disease/ treatment
  • • Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules

      ea0056gp265
    • Radiofrequency ablation for benign symptomatic thyroid nodules: evaluation of clinical efficacy

      ea0056gp266
    • Abstract unavailable

      ea0056gp267
    • Response to Liothyronine therapy: Efficiacy of therapy and assessment of biochemical and physiological predictors

      ea0056gp268
    • Tailored thyroxine treatment and gastric acid output in humans

      ea0056gp269
    • Body composition changes during treatment of severe thyroid disorders. Is it always fat?

      ea0056gp270
    • Personalised euthyroid targets based on a deterministic mathematical model

      ea0056gp271
    • US-guided percutaneous microwave ablation for benign thyroid nodules: a prospective multicenter study

      ea0056gp272
    • Abstract unavailable

      ea0056gp273
    • Reduced quality of life and persistent complaints in treated hypothyroid patients

      ea0056gp274
• Poster Presentations: Adrenal and Neuroendocrine Tumours
• • Adrenal cortex (to include Cushing's)
  • • Congenital adrenal hyperplasia in lady with severhirsutism and virilization due to 3B-hydroxysteroid dehydrogenase deficiency

      ea0056p1
    • Endogenous stimulation in adrenal venous sampling (AVS) in differential diagnosis of primary hyperaldosteronism (PA)

      ea0056p2
    • Congenital adrenal hyperplasia in 46xx male

      ea0056p3
    • Diagnostic difficulties of Pseudo-Cushing states in women: about 24 cases

      ea0056p4
    • Abstract unavailable

      ea0056p5
    • Is adrenocortical carcinoma in children a different spectrum?

      ea0056p6
    • Travelling distance and support group participation in patients with chronic adrenal insufficiency

      ea0056p7
    • Abstract unavailable

      ea0056p8
    • Evaluation of tumor size and hormonal status of elderly with adrenal incidentaloma

      ea0056p9
    • Evaluation of adrenal function in Cushing's syndrome model rats

      ea0056p10
    • Does Hemodialysis (HD) affect the overall testosterone (T) and luteinizing hormone (LH) levels in T-treated hypogonadal Congenital Adrenal Hyperplasia (CAH) male with associated chronic kidney disease (CKD)? A pilot single center matched case report

      ea0056p11
    • A rare case of Cushing's syndrome due to adrenal adenoma complicated by familial adenomatous polyposis

      ea0056p12
    • Hypoglycemic coma as first manifestation of primary adrenal insufficiency in a septic patient with severe hypokalemia and hypomagnesemia

      ea0056p13
    • Preoperative treatment with metyrapone in patient with Cushing's syndrome due to adrenal adenoma: a pilot prospective study

      ea0056p14
    • Clinical features of adrenal incidentalomas

      ea0056p15
    • Rare incidence of primary adrenocortical carcinosarcoma: a case report

      ea0056p16
    • Clinical and biochemical outcomes in surgically treated patients with primary aldosteronism. A multicentric retrospective study

      ea0056p17
    • Intraoperative hypertensive crisis as a key symptom in a normotensive patient with primary aldosteronism - clinical case

      ea0056p18
    • Adrenal insufficiency during prednisolone treatment in patients with polymyalgia rheumatica or giant cell arteritis - prevalence and clinical approach

      ea0056p19
    • Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre

      ea0056p20
    • Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism

      ea0056p21
    • Conn Syndrome Presented with Muscle Weakness

      ea0056p22
    • Large Oncocytic Adrenocortical Tumor with Uncertain Malignant Potential

      ea0056p23
    • Conjugated steroids could be a reserve stock for rapid conversion into free ones during stress

      ea0056p24
    • Presence of comorbidities related to hypercortisolism in a case series on adrenal incidentaloma (AI)

      ea0056p25
    • Increased levels of Interleukin-6 in patients with primary and secondary hypocortisolism: A case-control study

      ea0056p26
    • A new ARMC5 mutation responsible for primary bilateral macronodular adrenal hyperplasia

      ea0056p27
    • Abstract unavailable

      ea0056p28
    • Secondary adrenal insufficiency - is not this diagnosis often made too hasty?

      ea0056p29
    • Assessing the new Primary Aldosteronism guidelines recommendation to omit confirmatory testing in selected patients - severity of hypokalaemia may be included

      ea0056p30
    • Addison's disease due to adrenal tuberculosis: A case report

      ea0056p31
    • How can cortisol-normalized adrenal venous sampling miss some Conn's adenoma

      ea0056p32
    • ACTH stimulation test for study of primary aldosteronism

      ea0056p33
    • Value of 131I-Norcholesterol scintigraphy in the evaluation of primary hyperaldosteronism

      ea0056p34
    • A four months infant survival case of waterhouse-friderichsen syndrome

      ea0056p35
    • Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent

      ea0056p36
    • Utility of adrenal venous sampling for the differential diagnosis of primary hyperaldosternoism subtypes

      ea0056p37
    • Non-classic congenital adrenal hyperplasia clinics characteristics and treatment response cohort study

      ea0056p38
    • A rare incidentaloma: adrenal schwannoma

      ea0056p39
    • Cardiovascular risk in patient with incidentally detected adrenal masses - associated with metabolic syndrome and hypercortcism

      ea0056p40
    • Outcomes of patients undergoing surgery for primary aldosteronism based on adrenal venous sampling and/or radiological lateralisation indicate a role for both modalities in case selection

      ea0056p41
    • The response of C19- Δ5-steroids to ACTH stimulation

      ea0056p42
    • Non-classical form of congenital adrenal hyperplasia in patients with bilateral incidentalomas - hormonal and genetic analysis

      ea0056p43
    • Adrenal insufficiency in treated PMR: The tip of the iceberg

      ea0056p44
    • Decreased quality of life in male patients with primary adrenal insufficiency of Indian origin

      ea0056p45
    • The measurement of the renin-angiotensin-aldosterone system in patients with adrenal tumors with arterial hypertension

      ea0056p46
    • The renin-angiotensin-aldosteron system in primary adrenal insufficiency

      ea0056p47
    • Percutaneous microwave ablation of adrenal remnant tissue. A novel treatment modality for persistent Cushing's disease

      ea0056p48
    • Risk estimator for autonomous cortisol secretion in adrenal incidentalomas. Retrospective study of 100 cases

      ea0056p49
    • Is the adrenal vein sampling the gold standard diagnostic test for the subtyping of primary aldosteronism?

      ea0056p50
    • A descriptive study of patients with adrenocortical carcinoma treated in hospital clinico san carlos (HCSC) over the last 20 years

      ea0056p51
    • Bilateral adrenalectomy for occult ectopic Cushing's syndrome in two patients with catastrophic hypercortisolism

      ea0056p52
    • In vitro effects of KCNJ5 mutations on cellular death mechanisms

      ea0056p53
    • The role of DHEAS in the diagnosis of possible autonomous cortisol secretion by incidentally discovered adrenal adenomas

      ea0056p54
    • Abnormal salivary cortisol result in patient with low probability of Cushing disease

      ea0056p55
    • Improved salivary cortisol rhythm with dual-release hydrocortisone

      ea0056p56
    • A case of adrenal Cushing's syndrome initially presenting with diabetic ketoacidosis

      ea0056p57
    • The diagnostic accuracy of increased late night salivary cortisol for Cushing's Syndrome: a real-life prospective study

      ea0056p58
    • Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas

      ea0056p59
    • Expert patients are better prepared to survive adrenal crisis than most - but still lack training in injection method

      ea0056p60
    • Histopathological characteristics of lipid-poor adrenal adenomas

      ea0056p61
    • Different biological and functional features in patients with Cushing's disease harboring micro- or macro-adenomas

      ea0056p62
    • Salivary cortisol as a diagnostic tool for hypercortisolism in Cushing's syndrome and adrenal incidentaloma

      ea0056p63
    • Bilateral macronodular adrenal hyperplasia with autonomous cortisol secretion

      ea0056p64
    • A systematic survey of low S-cortisol levels at the department of clinical chemistry: indications for testing and frequency of undiagnosed adrenal insufficiency

      ea0056p65
    • Evaluation of cardiometabolic profile of patients submitted to unilateral adrenalectomy

      ea0056p66
    • Adrenal venous sampling in patients with ACTH-independent Cushing's syndrome

      ea0056p67
    • Association of the BclI glucocorticoid receptor polymorphism with metabolic parameters in female patients with adrenal incidentalomas

      ea0056p68
    • Adrenocortical carcinoma in the experience of one clinical center

      ea0056p69
    • Adrenocortical carcinoma: retrospective analysis of a series of clinical cases

      ea0056p70
  • Adrenal medulla
  • • Imaging characteristics of pheochromocytomas

      ea0056p71
    • Genetics in pheochromocytoma and paraganglioma: a case series

      ea0056p72
    • Analysis of a pheochromocytoma case series over 12 years: a specialty hospital experience

      ea0056p73
    • Laparoscopic surgery for pheochromocytoma: perioperative outcomes

      ea0056p74
    • Malignant pheochromocytoma discovered upon consultation for painful erections

      ea0056p75
    • Can patients with a large sporadic pheochromocytoma and very high norepinephrine secretion be normotensive? Yes, they can!

      ea0056p76
    • Pheochromocytoma revelation modalities: about 23 cases

      ea0056p77
    • When the large tumor is not the first intention for removal-concomitant discovery of left adrenal pheochromocytoma and a possible retroperitoneal plexiform neurofibroma in a case of familial neurofibromatosis type 1- case report

      ea0056p78
    • Why is it important to screen secondary endocrine hypertension in resistant cases? Lessons from a patient with progressive renal failure

      ea0056p79
    • Association of pheochromocytoma and neurofibrematosis type1: about 4 cases

      ea0056p80
    • A retrospective audit on the peri-operative management of phaeochromocytomas: [ldquo]Phenoxybenzamine or Doxazosin[rdquo]?

      ea0056p81
  • Calcium ' Vitamin D metabolism
  • • 25-OH vitamin D concentration and inflammation indicators in patients with non-functioning adrenal incidentalomas

      ea0056p82
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Arterial hypertension from the adrenal gland: Prognosis and predictive factors of recovery after chirurgical treatment

      ea0056p83
    • Metabolic and hormonal profile in primary aldosteronism as compared with essential hypertension

      ea0056p84
    • Aortic root dilatation in primary aldosteronism: is treatment effective in reducing aortic damage?

      ea0056p85
  • Clinical case reports - Pituitary/Adrenal
  • • Abstract unavailable

      ea0056p86
    • Long-term follow-up of congenital adrenal hyperplasia due to 11[beta]-hydroxylase deficiency

      ea0056p87
    • Rhabdomyolysis in a case with severe hypokalemia and Primary Hyperaldosteronism

      ea0056p88
    • Pheochromocytoma in young patient-challenges in clinical practice

      ea0056p89
    • Opioid-induced secondary adrenal insufficiency

      ea0056p90
    • Intracerebral hemorrhage as a first sign of pheochromocytoma

      ea0056p91
    • Severe pheochromocytoma crisis, Type B, resulting in Takotsubo-like cardiomyopathy and fulminant refractory cardiogenic shock, successfully treated with extracorporeal membrane oxygenation (ECMO) but with fatal neurological sequelae for the patient.

      ea0056p92
    • Functionig adrenal incidentaloma false positive for 18F-FDG-PET/TAC

      ea0056p93
    • Difficult Management of Autoimmune Polyglandular Syndrome Type 1

      ea0056p94
    • Pitfalls in differential diagnosis of adrenal masses

      ea0056p95
    • From gastric sleeve to diagnosis of a rare familial multiple endocrine neoplasia type 1

      ea0056p96
    • Primary adrenal lymphoma in an HIV patient: a rare case of bilateral adrenal tumors

      ea0056p97
    • High Adrenocorticotropic Hormone before and after bilateral adrenal surgery

      ea0056p98
    • Addison's disease due to bilateral adrenal hemorrhage as the first presentation of diffuse large B-cell lymphoma

      ea0056p99
    • 17- [alpha] hydroxylase deficiency in an adult female patient with hypertention and hypokalemia

      ea0056p100
    • Li-Fraumeni syndrome and adrenal tumours: case report

      ea0056p101
    • Addison's disease due to bilateral adrenal hemorrhage as the firstpresentation of diffuse large B-cell lymphoma

      ea0056p102
    • Paraganglioma of the prostate: a case report

      ea0056p103
    • A new gene - TMEM127 - in familial pheochromocytoma/paraganglioma syndromes

      ea0056p104
    • Bilateral adrenal mass revealing a pheochromocytoma and an adrenocortical adenoma in a young women: a case report

      ea0056p105
    • Cushing's syndrome in a patient with systemic lupus erythematosus

      ea0056p106
  • Clinical case reports - Thyroid/Others
  • • Searching for the cause of high HCG in a man

      ea0056p107
    • Syndrome carney-stratakis, new mutation report: SDH B: D138Y (c.412>T)

      ea0056p108
    • Challenges in the diagnosis and treatment of GEP NEN: a case report

      ea0056p109
  • Endocrine tumours and neoplasia
  • • Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors

      ea0056p110
    • Effect of 177 Lu-dotatate on severe, life-threatening, and refractory hypoglycemia associated with malignant insulinoma

      ea0056p111
    • Morphological changes of the adrenal glands with hypertension with a crisis current

      ea0056p112
    • Atypical manifestation of adrenocortical carcinoma - case series

      ea0056p113
    • Are there any clinical predictor for malignancy in malignant pheochromocytoma?

      ea0056p114
    • New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling

      ea0056p115
    • Outcome of adjuvant mitotane therapy in patients with adrenocortical carcinoma: the experience of San Luigi Gonzaga Hospital

      ea0056p116
    • Adrenocortical carcinoma - characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years

      ea0056p117
    • Comparative study between familial and sporadic pheochromocytoma

      ea0056p118
    • Clinical features, management and outcomes of adrenocortical carcinoma: a case series analysis

      ea0056p119
    • A case of multiple endocrine neoplasia type 1 (MEN1) with non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) responding to medical treatment with diazoxide

      ea0056p120
    • A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation

      ea0056p121
    • Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous sampling prior to adrenalectomy.

      ea0056p122
    • Hormonal secretion prevalence in a series of subjects with adrenal tumors incidentally discovered in clinical practice

      ea0056p123
    • Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation

      ea0056p124
    • Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing

      ea0056p125
    • Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort

      ea0056p126
    • Adrenocortical cancer - the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose

      ea0056p127
    • Ghrelin is overexpressed in adrenal cancers and stimulates proliferation and migration of ACC cell line.

      ea0056p128
    • The effect of temozolomide on pancreatic neuroendocrine tumours and role of MGMT and MMR system in temozolomide resistance

      ea0056p129
    • Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

      ea0056p130
    • Severe impairments in health-related quality of life in patients with small intestine neuroendocrine tumors

      ea0056p131
    • Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma

      ea0056p132
    • Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior

      ea0056p133
    • Mesenchymal tissue markers as potential drug targets in adrenocortical tumours

      ea0056p134
    • Multiple endocrine neoplasia type 1: a retrospective monocenter analysis of 73 cases

      ea0056p135
    • Cell line derived from glioblastoma synthesizes steroid hormone. Effect of enzyme inhibitors

      ea0056p136
    • Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

      ea0056p137
    • Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

      ea0056p138
    • Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening

      ea0056p139
    • Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients

      ea0056p140
    • Patients with metastatic bone disease and neuroendocrine neoplasms: the experience of a multi-center study

      ea0056p141
    • Clinical features of 'dedifferentiation' in advanced pancreatic neuroendocrine neoplasms: the experience of two centers of excellence

      ea0056p142
    • Clinical features of a gastric neuroendocrine neoplasms type 1 series

      ea0056p143
  • Female Reproduction
  • • Female fertility in congenital adrenal hyperplasia

      ea0056p144
  • Neuroendocrinology
  • • Non-functional duodenal neuroendocrine carcinoma- a rare cause of diabetes mellitus

      ea0056p145
    • Preliminary study of POU1F1 (Pit1) gene expression in lactotroph and thyrotroph neuroendocrine tumours

      ea0056p146
    • Ectopic cushing's syndrome: Six cases description

      ea0056p147
    • Metastatic meduller thyroid cancer patient with MEN 2B who developed acute leukemia

      ea0056p148
    • Diagnostic difficulties, management and treatment in neuroendocrine tumors

      ea0056p149
    • Through five hospitals and 800 km, a long way from emergency department to insulinoma operation

      ea0056p150
    • A rare association of neuroendocrine tumors

      ea0056p151
    • Head and neck paragangliomas: genetic mutation and location of the tumors

      ea0056p152
    • Bilateral neck paragangliomas in a patient with a family history and chronic hypoxemia

      ea0056p153
    • The first experience of using of ultrasound with multimodal imaging technology for the diagnosis of pancreatic insulinoma

      ea0056p154
  • Obesity
  • • Body composition and concentration of 25-OH vitamin D as metabolic syndrome indicators in patients with non-functioning adrenal incidentalomas

      ea0056p155
  • Paediatric endocrinology
  • • Pediatric adrenal insufficiency: experience from a Tertiary Hospital Center

      ea0056p156
  • Pituitary - Basic
  • • MicroRNA profile after octreotide treatment in neuroendocrine tumor cell line

      ea0056p157
    • Gender differences in delays to diagnosis of acromegaly: data from the Swedish National Patient Register

      ea0056p158
    • Direct costs after diagnosis of acromegaly: Data from Swedish nationwide registries

      ea0056p159
  • Steroid metabolism + action
  • • Urinary steroid profile in patients with primary adrenal insufficiency under conventional glucocorticoid replacement: a case control study

      ea0056p160
    • Steroid profile using gas chromatography tandem mass spectrometry (GC-MS/MS) in search for a steroid which correlates most with subclinical hypercortisolism

      ea0056p161
  • Thyroid (non cancer)
  • • Clinical aspects of the schmidt's syndrome: a 14 years retrospective monocentric study

      ea0056p162
  • Thyroid cancer
  • • Abstract unavailable

      ea0056p163
• Poster Presentations: Calcium and Bone
• • Bone ' Osteoporosis
  • • Influence of the levels of vitamin D on T-score in HIP measured by DXA of colombian postmenopausal women

      ea0056p164
    • Potential extension of frax algoritm and probability of bonefracture

      ea0056p165
    • A case report: FGF23-related tumor-induced osteomalacia in a patient with pulmonary adenocarcinoma

      ea0056p166
    • Abstract unavailable

      ea0056p167
    • Features of distal forearm fracture in persons 50 years old and older

      ea0056p168
    • Effect of surgery vs observation: 6-Year skeletal outcomes in primary hyperparathyroidism

      ea0056p169
    • Association between Serum FGF21 levels and bone mineral density in healthy postmenopausal Korean women

      ea0056p170
    • Bone geometry is correlated with arterial stiffness in overweight older adults with vitamin D insufficiency

      ea0056p171
    • Effects of acromegaly on plasma microRNA levels relevant to bone metabolism.

      ea0056p172
    • Is FGF23 a key factor in primary hyperparathyroidism?

      ea0056p173
    • Long-term monitoring of echinococcal cyst as a cause of increased lumbar bone mineral density

      ea0056p174
    • Acromegaly patients with vertebral fractures, have lower trabecular bone score despite no difference in bone mineral density, than non-fractured patients and healthy controls

      ea0056p175
    • Atypical femoral fracture-a possible complication in long term use of bisphosphonates (case report)

      ea0056p176
    • Malignant hypercalcemia induced by denosumab discontinuation in a patient with primary hyperparathyroidism

      ea0056p177
    • An extremely high risk of recurrent fractures in an elderly patient, identified with the implementation of Fracture Liaison Service (FLS) in a trauma hospital.

      ea0056p178
    • The comparison of parathyroid neoplasms mappings evaluated by using gray scale ultrasound images and histopathological whole slide images

      ea0056p179
    • Evaluation of bone mineral density and vertebral fracture incidence in a group of kidney transplant recipients

      ea0056p180
    • PTH correlates with bone turnover serum markers in patients with end stage renal disease

      ea0056p181
    • Rapid washout in primary, secondary, and tertiary hyperparathyroidism and utility of dual radiopharmaceutical acquisition with 99 Tc-sestamibi-123I for localization of parathyroid adenomas

      ea0056p182
    • Trabecular bone score in patients with active acromegaly

      ea0056p183
    • Gut and bone connection: celiac disease presented as hypertrophic osteoarthropathy

      ea0056p184
    • The main bone mass predictors in healthy young and middle-aged men: lean mass and estradiol

      ea0056p185
    • Teriparatide treatment in a patient with atypical femoral fractures associated with long-term bisphosphonate therapy

      ea0056p186
    • Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma

      ea0056p187
    • Bone mineral density decline following denosumab discontinuation might not be attenuated with previous bisphosphonate therapy

      ea0056p188
    • Novel heterozygous mutation of tissue-non-specific alkaline phosphatase (TNSALP) gene causing late-onset hypophosphatasia

      ea0056p189
    • Orthopedic patient with hearing impairment and dizziness due to the undiagnosed Paget's disease of bone

      ea0056p190
    • Tumor-induced osteomalacia associated with mesenchymal tumor: a challenging case report

      ea0056p191
    • Osteoprotegerin and bone metabolism markers in postmenopausal women with primary hyperparathyroidism

      ea0056p192
    • Endocrine osteoporosis characteristics (about 177 cases)

      ea0056p193
    • Osteoprotegerin and distal radius bone mineral density in postmenopausal women with primary hyperparathyroidism

      ea0056p194
    • Cystic fibrosis-related bone disease in young adults affected with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure

      ea0056p195
    • Recurrent vertebral fracture after denosumab discontinuation in a male patient with severe osteoporosis

      ea0056p196
    • Microindentation in the study of bone properties for type 1 diabetes mellitus patients

      ea0056p197
    • Relationships between hormonal parameters, body fat distribution and bone mineral density in women with menstrual disorders

      ea0056p198
    • Long term follow up of patients with hypophosphatemic rickets in a Public Institution in Brazil

      ea0056p199
    • Genetic polymorphisms may modulate bone and energy metabolism of mountain cycling ultramarathon athlete's

      ea0056p200
    • May polymorphisms of DHFR, CBS and MTHFR genes modulate metabolic and bone remodeling parameters associated with reduced bone mineral density?

      ea0056p201
  • Calcium & Vitamin D metabolism
  • • Vitamin D levels in two ethnic groups of patients with diabetes

      ea0056p202
    • Effects of steroid hormone on Calbindin-D9k expression in rat cerebellum

      ea0056p203
    • Effects of glucocorticoid on mucin secretion by calcium-related proteins in mouse lung

      ea0056p204
    • Effect of endocrine disrupting chemicals on the calcium channel and implantation during implantation period

      ea0056p205
    • Clinical, paraclinical, etiological and therapeutic particularities of severe hypercalcemia: A comparative study

      ea0056p206
    • Genetic characteristics of sensitivity of vitamin D and prevalence of vitamin deficiency among patients of polyclinics

      ea0056p207
    • A Curious phenomenon of Post radioiodine therapy induced hypocalcemia in Graves' disease: Case series

      ea0056p208
    • Primary hyperparathyroidism in the elderly

      ea0056p209
    • Edentulous jaw and Primary HyperParathyroidism

      ea0056p210
    • Coeliac Disease complicating Autoimmune Hypoparathyroidism with Recalcitrant Hypocalcaemia

      ea0056p211
    • The prevalence of Vitamin D deficiency in a Greek and a Cypriot population sample

      ea0056p212
    • Epidemiology of primary hyperparathyroidism in Santander, Spain

      ea0056p213
    • Human Chorionic Gonadotrophin (hCG) as a diagnostic test to differentiate between Parathyroid Carcinoma, Primary Benign Hyperparathyroidism and Secondary Hyperparathyroidism.

      ea0056p214
    • Reliabilty of serum Calcium to Phosphorus (Ca/P) ratio as an accurate and inexpensive toolto define disorders of Ca-P metabolism: preliminary data

      ea0056p215
    • Secondary hyperparathyroidism after obesity surgery is associated with serum levels of 25-hydroxyvitamin D and ionized calcium

      ea0056p216
    • The frequencies of persistent hyperparathyroidism and hypercalcemia after kidney transplantation: a single-center experience

      ea0056p217
    • Prevalence and clinico-epidemiology of vitamin D deficiency in patients with type 2 diabetes mellitus and hypertension - a Pan-India study

      ea0056p218
    • PTH threshold for hyperparathyroidism diagnosis in vitamin D deficiency

      ea0056p219
    • Vitamin D status in hospitalized chronic ill patients

      ea0056p220
    • Role of 4D-TC in Primary Hyperparathyroidism Diagnosis- case report

      ea0056p221
    • Severe hypomagnesaemia and hypocalcaemia: an uncommon but serious complication with proton pump inhibitor therapy

      ea0056p222
    • Hip fractures and vitamin D deficiency

      ea0056p223
    • Clinical manifestation of Hypoparathyroidism in a monocentric cohort: our experience

      ea0056p224
    • Primary hyperparathyroidism due to a parathyroid adenoma with cystic degeneration presenting as recurrent acute pancreatitis

      ea0056p225
    • Glucose metabolism in primary hyperparathyroidism: The role of parathyroidectomy

      ea0056p226
    • Acquired Fanconi syndrome and hypophosphatemic osteomalacia in two patients treated with adefovir and tenofovir

      ea0056p227
    • The coexistence of primary hyperparathyroidism with different auto-antibodies and autoimmune diseases

      ea0056p228
    • Timely and dose assessment of serum parathormone and calcium levels by cinacalcet in patients with primary hyperparathyroidism: an individualized approach

      ea0056p229
    • Coexistence of a large functioning parathyroid cyst with papillary thyroid carcinoma: a case report

      ea0056p230
    • Assessment of calcium and vitamin D medications adherence in patients with hypoparathyroidism after thyroidectomy

      ea0056p231
    • Preoperative serumvitamin D levels in patients with breast cancer: association with histological characteristics

      ea0056p232
    • Association of vitamin D status with pulmonary function: potential mediation by physical function and inflammation

      ea0056p233
    • Quantification of serum 25-hydroxyvitamin D: a comparison between competitive chemiluminescence immunoassay and mass spectrometry coupled to high performances liquid chromatography

      ea0056p234
    • Maximal foot force and plantar pressure distribution assessed by Footscan is not affected in asymptomatic primary hyperparathyroidism patients

      ea0056p235
    • Primary hyperparathyroidism in Russian Federation: epidemiology according to the online register

      ea0056p236
    • Intrathyroidal parathyroid carcinoma in a chronic hemodialysis patient: a case report

      ea0056p237
    • Raloxifene has no efficacy in reducing the risk of spontaneous vertebral fractures after denosumab discontinuation

      ea0056p238
    • Prevalence of basal ganglia calcification in patients with pseudohypoparathyroidism

      ea0056p239
    • Thyroid oncocytes may complicate 18F-fluorocholine PET-CT localization of parathyroid adenomas in primary hyperparathyroidism

      ea0056p240
    • Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception

      ea0056p241
    • Abstract unavailable

      ea0056p242
    • PTH secretion dynamics in patients with chronic kidney disease stage 3 and stage 4 during 1 year of observation

      ea0056p243
    • Biological and endocrine features of Infra Clinical Hypoparathyroidism in Major Beta Thalassemia at adulthood in Algeria, screening and therapeutic management

      ea0056p244
    • Impact of vitamin D status in clinical, biochemical, radiological and pathological parameters in primary hyperparathyroidism

      ea0056p245
    • Milk alkali syndrome & soft tissue calcification in a patient with a history of cancer

      ea0056p246
    • Management of parathyroid adenomas

      ea0056p247
    • Recurrent hyperparathyroidism: parathyroid carcinoma or parathyromatosis?

      ea0056p248
    • Prenatal hypophosphatasia with severe skull bone deficits report of a case

      ea0056p249
    • Clinical outcome in primary hyperparathyroidism: A 10-year tertiary care centre experience in Pakistan

      ea0056p250
    • Primary hyperparathyroidism-localisation studies' sensitivity

      ea0056p251
    • Characterization of the parathyroid hormone requests and hyperparathyroidism etiologies in a tertiary hospital

      ea0056p252
    • Tertiary hyperparathyroidism associated with prolactinoma - case report

      ea0056p253
    • Effect of bariatric surgery on free vitamin D3 levels

      ea0056p254
    • Utility of contrast-enhanced ultrasound in preoperative evaluation of primary hyperparathyroidism

      ea0056p255
    • Abstract unavailable

      ea0056p256
    • Primary hyperparathyroidism after thyroid surgery and autotransplantion of parathyroid gland

      ea0056p257
    • Metabolic encephalopathy following intravenous zolendronate for hypercalcaemia of malignancy: a perfect storm

      ea0056p258
    • Primary hyperparathyroidism: a rare cause of hypertension?

      ea0056p259
    • Atypical Parathyroid adenoma in a young individual, presented with nephrocalcinosis

      ea0056p260
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Is there a relationship between mean platelet volume as a cardiac marker and serum calcium levels in patients with parathyroid disease

      ea0056p261
  • Clinical case reports - Pituitary/ Adrenal
  • • Hypercalcemia, hypercortisolism and multiple vertebral fractures in a 49-year-old man

      ea0056p262
  • Clinical case reports - Thyroid/Others
  • • Severe hypercalcemia due to atypical parathyroid adenoma

      ea0056p263
    • Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor: case report

      ea0056p264
    • Utility of 11C-methionine PET/CT in preoperative localization of a parathyroid adenoma in a patient with primary hyperparathyroidism: a case report

      ea0056p265
    • Ulnar osteoclastoma as first manifestation in primary hyperparathyroidism: case report

      ea0056p266
    • Lithium-associated Hyperparathyroidism in a Filipino woman presenting as recurrent ischemic stroke: a case report

      ea0056p267
    • Looked like a goiter, proved to be a giant parathyroid adenoma

      ea0056p268
    • Concomitant primary hyperparathyroidism with papillary thyroid carcinoma: The role of dual-phase 99mTc-MIBI parathyroid imaging: case report

      ea0056p269
    • Multiple brown tumors inprimary hyperparathyroidismcaused by an adenoma mimicking metastatic bone disease with false positive results on computed tomography

      ea0056p270
    • Regression of multipl brown tumors after surgical removal of mediastinal ectopic parathyroid adenoma

      ea0056p271
    • Multiple hormone resistance in a patient with follicular thyroid carcinoma and papillary microcarcinoma

      ea0056p272
    • Hypercalcemia not mediated by PTH: a case report

      ea0056p273
    • Papillary thyroid cancer and primary hyperparathyroidism - a rare coincidence: case report

      ea0056p274
  • Endocrine Disruptors
  • • Role of Pro-inflammatory cytokines in Primary Hyperparathyroidism: A Prospective Study

      ea0056p275
  • Endocrine Nursing
  • • Prevalence of kidney stones and osteoporosis in patients with primary hyperparathyroidism

      ea0056p276
  • Endocrine tumours and neoplasia
  • • Somatostatin receptors 1 and 5 are novel markers of parathyroid tumor aggressiveness

      ea0056p277
    • Vitamin D and cancer of the prostate

      ea0056p278
    • Feasibility and efficacy in ultrasound guided percutaneous microwave ablation of primary hyperparathyrodism with parathyroid nodules

      ea0056p279
  • Female Reproduction
  • • Association between age at onset of menopause and fracture risk: a systematic review and meta-analysis

      ea0056p280
• Poster Presentations: Diabetes, Obesity and Metabolism
• • Adrenal cortex (to include Cushing's)
  • • Hypoglycemia in non-diabetic patients: clinical features and causes

      ea0056p281
  • Bone & Osteoporosis
  • • First report of Gaucher disease in Montenegro: Genotype/phenotype correlations

      ea0056p282
    • Hip axis length in women with type 1 diabetes mellitus

      ea0056p283
    • Vertebral fractures in patients with type 2 diabetes mellitus

      ea0056p284
    • Vertebral fractures in women with type 1 diabetes mellitus

      ea0056p285
    • Proximal femur structural geometry changes in women with type 2 diabetes mellitus

      ea0056p286
    • Case report: male adult with autosomal-dominant osteopetrosis

      ea0056p287
    • Fragility index in type 2 diabetes for identification of patients with risk of osteoporotic fracture or prevalent fracture

      ea0056p288
  • Calcium & Vitamin D metabolism
  • • Relationships between vitamins and lipids in the elderly

      ea0056p289
    • Vitamin D and obesity

      ea0056p290
    • Vitamin D deficiency and risk of metabolic syndrome

      ea0056p291
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial

      ea0056p292
    • Your patients say they do not tolerate statins? You can still lower their cardiovascular risk with red yeast rice supplementation

      ea0056p293
    • Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice

      ea0056p294
    • B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.

      ea0056p295
    • Relationship between the triglyceride glucose index and the presence and fibrosis of nonalcoholic fatty liver disease in Korean adults

      ea0056p296
    • Adropin concentration correlates with selected anthropometric and biochemical parameters - preliminary report

      ea0056p297
    • Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease

      ea0056p298
    • PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice

      ea0056p299
    • Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico

      ea0056p300
    • Searching the best feeding habits to improve atherogenic dyslipidemia and inflammatory activity in patients with psoriatic arthritis

      ea0056p301
    • Worse MELD score is linked to a higher rate of metabolic syndrome in HIV/HCV co-infected patients on highly active antiretroviral therapy

      ea0056p302
    • Improved lipid profile and cardiovascular risk factors after bariatric surgery

      ea0056p303
    • Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

      ea0056p304
    • Plasma insulin levels in patients with the different severity of atherosclerotic lesions of coronary arteries

      ea0056p305
    • A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective

      ea0056p306
    • A case of combined dyslipidemia with two different defined genetic alterations

      ea0056p307
    • Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk

      ea0056p308
    • Comparison of inflamatory parameters, lipid profile and clinical values in patients with clinical and subclinical hypothyroidism

      ea0056p309
    • High levels of sclerostin are related to cardiovascular mortality

      ea0056p310
    • Lipid profile after pregnancy in women with gestational diabetes mellitus

      ea0056p311
    • Secondary diabetes associated with principal endocrinopathies (about 161 cases)

      ea0056p312
    • Metabolic syndrome and triglyceride-rich lipoproteins

      ea0056p313
    • Specificity of mathematical indexes versus histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population

      ea0056p314
    • What changes does pregnancy bring to the lipid parameters of diabetic patients?

      ea0056p315
    • Identifying metabolic unhealthy obesity using the product of triglycerides and glucose

      ea0056p316
  • Clinical case reports - Thyroid/Others
  • • Diabetic ketoacidosis occurring in the patient whom newly started insulin glargine U300: a case report

      ea0056p317
    • A female patient with diabetic ketoacidosis who had hyperthyroidism and acute appendicitis

      ea0056p318
    • Factitious hypoglycemia; Case report

      ea0056p319
    • Development of fatal lactic acidosis after inadvertent use of metformin in a non-diabetic hemodialysis patient

      ea0056p320
    • Effect of hemoglobin J variant on HbA1c values as measured by HPLC (high-perfomance liquid chromatography)

      ea0056p321
    • Performance-enhancing drugs and adverse endocrine effects

      ea0056p322
    • Maturity - onset diabetes in the young and non-alcoholic fatty liver disease: a case report

      ea0056p323
    • Dapagliflozin and Atkins Diet in a patient with type 2 Diabetes Mellitus: A combination that should be avoided

      ea0056p324
    • A rare cause of hypoglycemia: insulin autoimmune syndrome in a Turkish patient taking Alpha lipoic acid

      ea0056p325
    • Post bariatric surgery malabsorption and vitamin D deficiency

      ea0056p326
    • Diabetes and bulimia - a dangerous combination

      ea0056p327
    • Prolonged hyperglycemia in a type 1 diabetic futsal player after a single betamethasone injection for pain in the groin area

      ea0056p328
  • Developmental endocrinology
  • • Glucose, lipids, and insulin in cord blood of neonates and their association with birth weight

      ea0056p329
    • Association of RS1170806 polymorphism in ADCY5 and RS7754840 polymorphism in CDKAL1 with birth weight, neonatal glucose, insulin and insulin resistance.

      ea0056p330
  • Diabetes (to include epidemiology, pathophysiology)
  • • Evaluation of community pharmacy-based services for type-2 diabetes in an Albanian setting: pharmacist survey

      ea0056p331
    • Estimation of HbA1c in hospitalized patients with bronchial asthma

      ea0056p332
    • Inpatient diabetes management service, 30-day readmissions and length of stayof patients with diabetes

      ea0056p333
    • Evolution of the degree of glycemic control in a cohort of patients with type 2 diabetes mellitus. study to 26 weeks

      ea0056p334
    • Study of the association of transcription factor 7 like 2 gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy in the Egyptian population

      ea0056p335
    • Relationship between serum zinc, glycemic status and HOMA2 parameters in a regional Australian hospital population

      ea0056p336
    • The role of polysomnography for detection of OSA in patients with type 2 diabetes in the Uzbek population

      ea0056p337
    • Transcription Factor 7 Like2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus in a cohort of Egyptian diabetic patients, a pilot study

      ea0056p338
    • Undiagnosed diabetes and related risk factors in postmenopausal women: the 2011-2012 Korean National Health and Nutrition Examination Survey

      ea0056p339
    • Comparison of quality of life and symptoms of depression in diabetes combined with gastroparesis and without it

      ea0056p340
    • Predictors of anxiety development at diabetes mellitus type 1

      ea0056p341
    • Comparative analysis of the prevalence of type 2 diabetes according to the screening and register data in Uzbekistan

      ea0056p342
    • Nutrition of non-fasting patients with diabetes during the month of Ramadan

      ea0056p343
    • Evaluation of procalcitonin levels in diabetic and diabetic nephropathic patients

      ea0056p344
    • Telmisartan increases gluconeogenesis by inducing PKCζ-Thr410 phosphorylation in hyperglycemia-treated HepG2 cells and high-fat diet-fed mouse liver

      ea0056p345
    • Diabetes complications and comorbidities in patients newly diagnosed with diabetes in newfoundland and labrador (NL): gender differences

      ea0056p346
    • Visfatin concentration and anthropometric/biochemical parameters in healthy individuals-preliminary study

      ea0056p347
    • Serum soluble vascular adhesion molecules and highly sensitive C: reactive protein in elderly type 2 diabetic patients with mild cognitive impairment

      ea0056p348
    • Evaluating quality of diabetic care in patients with severe mental illness (SMI) in an academic primary care clinic

      ea0056p349
    • Prorenin and secreted frizzled-related protein-4 levels in women with gestational diabetes mellitus

      ea0056p350
    • Novel inflammatory pathways in monocytes of type 2 diabetes patients are modulated by vitamin D

      ea0056p351
    • Serum adiponectin in male type 2 diabetic patients exposed to ionizing radiation in early years

      ea0056p352
    • Decreased spexin levels in patients with type 1 diabetes

      ea0056p353
    • Increase in C-peptide levels after short term glycemic control in patients with type 2 diabetes mellitus: myths or facts?

      ea0056p354
    • Incidence of glucocorticoid-induced hyperglycemia among hospitalized nondiabetic patients

      ea0056p355
    • Diabetes after liver transplantation

      ea0056p356